Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||
| Operating Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -282 | N/A | -4 |
| Net Acquisitions | N/A | -1,897 | 3 |
| Purchase Sale Intangibles | -46 | N/A | N/A |
| Investing Cash Flow | $-328 | $-1,897 | $-1 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -660 | -612 | -600 |
| Common Stock Issued | 31,681 | N/A | 45,669 |
| Other Financing Activity | -1,112 | 0 | -2,332 |
| Financing Cash Flow | $29,909 | $-612 | $42,738 |
| Exchange Rate Effect | -67 | 931 | N/A |
| Beginning Cash Position | 18,042 | 34,346 | N/A |
| End Cash Position | 31,222 | 18,153 | 38,032 |
| Net Cash Flow | $13,247 | $-17,125 | $N/A |
| Free Cash Flow | |||
| Capital Expenditure | -328 | N/A | -4 |
| Free Cash Flow | -328 | 0 | -4 |